Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Duo Yu

Showing results (81-90 of 85) with videos related to

Pageof 9
Sort By:
You have reached the last page of results.This site can display upto 85 results.
Neurosurgical Focus|May 2, 2020
Vasopressor treatment and mortality following nontraumatic subarachnoid hemorrhage: a nationwide electronic health record analysisGeorge Williams, Vahed Maroufy, Laila Rasmy, et al.
Gut|January 2, 2026
CD48 is a novel immune checkpoint on tumour-associated macrophages in hepatocellular carcinomaGege Shi, Yang Xiao, Zhaozhao Li, et al.
Scientific Reports|July 15, 2022
Validation and promise of a TCR mimic antibody for cancer immunotherapy of hepatocellular carcinomaChang Liu, Hong Liu, Moumita Dasgupta, et al.
Journal of the American Heart Association|December 11, 2025
PrevCardioOncAI: Machine Learning Algorithms for Predicting Cardiovascular Disease in Cancer SurvivorsSherry-Ann Brown, Michelle Z Fang, Rodney Sparapani, et al.
Journal of Nanobiotechnology|January 8, 2026
Targeting TRIM25 as a therapeutic strategy to enhance ferroptosis in glioblastoma cellsMaorong Zhu, Yuxin Wu, Huihui Ou, et al.
Pageof 9

Showing results (81-90 of 85) with videos related to

Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 85 results.
Neurosurgical Focus|May 2, 2020
Vasopressor treatment and mortality following nontraumatic subarachnoid hemorrhage: a nationwide electronic health record analysisGeorge Williams, Vahed Maroufy, Laila Rasmy, et al.
Gut|January 2, 2026
CD48 is a novel immune checkpoint on tumour-associated macrophages in hepatocellular carcinomaGege Shi, Yang Xiao, Zhaozhao Li, et al.
Scientific Reports|July 15, 2022
Validation and promise of a TCR mimic antibody for cancer immunotherapy of hepatocellular carcinomaChang Liu, Hong Liu, Moumita Dasgupta, et al.
Journal of the American Heart Association|December 11, 2025
PrevCardioOncAI: Machine Learning Algorithms for Predicting Cardiovascular Disease in Cancer SurvivorsSherry-Ann Brown, Michelle Z Fang, Rodney Sparapani, et al.
Journal of Nanobiotechnology|January 8, 2026
Targeting TRIM25 as a therapeutic strategy to enhance ferroptosis in glioblastoma cellsMaorong Zhu, Yuxin Wu, Huihui Ou, et al.
Pageof 9